Serbia grew to become one of many first European nations to obtain a Chinese-made COVID-19 vaccine on Saturday when a million doses of a jab produced by Sinopharm arrived at Belgrade airport.
President Aleksandar Vucic posted an image of himself on Instagram, standing subsequent to the aircraft carrying the vaccine.
“We are proud of our friendship with China,” he was quoted as saying by Beta information company, telling reporters that he hoped to be inoculated with the Sinopharm vaccine in six or seven days.
For extra coronavirus information, go to our devoted web page.
After Pfizer-BioNTech and Russia’s Sputnik V, Sinopharm’s is the third coronavirus vaccine for use by the Balkan nation.
Once the Chinese vaccine will get a closing approval by Serbia’s medicines company, vaccination might begin on Sunday or Monday, well being official Zoran Gojkovic stated earlier.
The European Union-candidate nation, which has additionally shut financial and political ties with Moscow and Beijing, began vaccination with Pfizer-BioNTech jabs on December 24 and later imported Russian Sputnik V vaccines.
For all the newest headlines comply with our Google News channel on-line or through the app.
Sinopharm says its vaccine is 79 % efficient in opposition to the novel coronavirus, in contrast with charges of 95 % and 94 % respectively for the rival jabs made by Pfizer-BioNTech and Moderna.
Another Chinese-made jab, Sinovac’s CoronaVac, was rolled out in Turkey on Thursday, after exams there confirmed it to be 91.25 % efficient.
But extra strong trials in Brazil demonstrated an efficacy fee of round 50 %.
So far, some 20,500 folks – residents of retirement properties and well being sector staff – have been vaccinated in Serbia, a rustic with a inhabitants of seven million, the nationwide immunization crew stated Friday.
Serbia has registered practically 370,000 infections and greater than 3,700 deaths from the novel coronavirus.
Read extra:
Coronavirus: Brazil researchers report modest 50.4 pct efficacy for China’s CoronaVac
Coronavirus: What we learn about China’s vaccine growth, efficacy knowledge, timelines
Coronavirus: UAE approves Sinopharm vaccine to be used after trials present 86 pct efficacy
SHOW MORE
Last Update: Saturday, 16 January 2021 KSA 17:35 – GMT 14:35
